Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 797.13B | 795.27B | 851.96B | 733.01B | 551.29B |
Gross Profit | 294.93B | 266.30B | 316.52B | 286.16B | 192.99B |
EBITDA | 205.29B | 190.92B | 240.55B | 230.32B | 157.62B |
Net Income | 147.56B | 133.16B | 170.59B | 155.27B | 94.01B |
Balance Sheet | |||||
Total Assets | 1.94T | 1.93T | 1.87T | 1.78T | 1.63T |
Cash, Cash Equivalents and Short-Term Investments | 606.50B | 539.08B | 529.23B | 601.22B | 586.78B |
Total Debt | 0.00 | 6.42B | 5.11B | 2.44B | 2.16B |
Total Liabilities | 197.14B | 206.84B | 245.98B | 234.09B | 189.64B |
Stockholders Equity | 1.72T | 1.71T | 1.62T | 1.54T | 1.43T |
Cash Flow | |||||
Free Cash Flow | 214.47B | 117.88B | 52.44B | 91.22B | 96.23B |
Operating Cash Flow | 255.27B | 171.76B | 99.50B | 125.58B | 118.00B |
Investing Cash Flow | -134.08B | -13.56B | -78.00B | -53.93B | -16.77B |
Financing Cash Flow | -136.62B | -122.51B | -127.92B | -89.15B | -53.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $95.24B | 27.48 | 27.42% | 0.92% | -0.40% | 24.40% | |
76 Outperform | $138.24B | 35.73 | 20.76% | 1.14% | 7.66% | 9.19% | |
73 Outperform | $75.62B | 28.86 | 10.86% | 1.57% | 4.78% | 59.68% | |
73 Outperform | $76.52B | 23.03 | 109.06% | 2.29% | -1.40% | 11.65% | |
71 Outperform | $39.07B | 40.77 | 28.46% | 1.51% | -8.23% | -3.29% | |
63 Neutral | $28.35B | 27.32 | 9.26% | 1.42% | 0.87% | 19.98% | |
59 Neutral | kr42.61B | 14.40 | 1.95% | 2.37% | 0.37% | -2.81% |